Join
Live feed
·
PRReleasevia Quantisnow
Tectonic Therapeutic Inc. logo

Tectonic Therapeutic Completes Enrollment in TX45 APEX Phase 2 Clinical Trial in PH-HFpEF Patients

ByQuantisnow·Wall Street's wire, on your screen.
TECX· Tectonic Therapeutic Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TECX (Tectonic Therapeutic Inc.) and more on Quantisnow.